La Jolla Institute Launches New RNAi Center | GenomeWeb

This article has been updated with quotes from La Jolla Institute President and CSO Mitchell Kronenberg.

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) –The La Jolla Institute for Allergy & Immunology today launched a new center that will focus on using RNAi to study the genetics involved in human diseases and to develop new therapies to combat those maladies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: transcriptional and translational study of human cytomegalovirus interactions with host cells, spider web DNA study, and more.

The New York Stem Cell Foundation signs a lease for a new space.

Researchers gear up for an international meeting to discuss the ethics of gene editing.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.

Sponsored by
HTG Molecular

This webinar will discuss potential clinical applications for miRNA signatures and a novel, extraction-free miRNA profiling technology for advancing biomarker discovery.